News

Press release

TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board

Dec 10, 2025

Download document ⤓

Read more
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients

Dec 08, 2025

Download document ⤓

Read more
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

Dec 05, 2025

Download document ⤓

Read more
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market

Dec 02, 2025

Download document ⤓

Read more
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel

Nov 26, 2025

Download document ⤓

Read more
TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

Nov 18, 2025

Download document ⤓

Read more
TempraMed to Support Beyond Type 1’s Beyond Type Run Team at the 2025 TCS New York City Marathon

Oct 27, 2025

Download document ⤓

Read more
TempraMed Announces Private Placement of up to C$2.5Million

Oct 21, 2025

Download document ⤓

Read more

© 2025 Tempramed • Terms of Use • Privacy Policy • Return Policy • Shipment Delivery

Secure Checkout: secure-amex

secure-amex

secure-mastercard

secure-paypal

secure-applepay

secure-jcb

secure-visa

secure-discover

secure-shoppay

secure-klarna

secure-afterpay

secure-affirm

secure-fsa

secure-hsa

Any information on this website is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before making health-related decisions.